Brice Davis was once best known for his soft-spoken nature in Xenia, Ohio. Today, he hopes his newly published book will guide others in times of struggle, reflecting lessons he learned during his own quiet upbringing.

A woman grapples with a newly confirmed cancer diagnosis that she has anticipated for years. Despite sharing the news with her children, she hesitates to tell her 100-year-old mother, who remains mentally sharp but physically frail.

Three residents of Talbot House Sober Living for Men have completed the 120-day Pearl Maker Program on July 3. Their graduation marks a critical step in their continued journey toward a healthier, sober lifestyle, supported by the dedicated staff and peers at Talbot House.

Addex has unveiled new research pointing to the crucial role of mGlu7 modulation in the control of sleep and wakefulness. Though details are limited, this announcement could mark a significant milestone for potential future therapies targeting sleep problems.

Parenting doesn’t end when a relationship does, yet getting along with an ex can feel impossible. Tensions run high when one parent dismisses concerns while the other sees growing problems—especially for their children caught in the middle.

A groundbreaking University of Arizona program is tackling campus loneliness through the power of art and culture. By offering activities in local galleries and theaters, Arizona Arts Rx has reduced student isolation by 60% and boosted mental health.

A memorial service takes center stage in a family conflict as one brother refuses to invite their late gay father’s ex-partner. Although the brother’s decision is questioned, the family grapples with whether his actions stem from homophobia or unprocessed emotions.

In June 2026, psychiatry saw developments that ranged from a delayed ADHD treatment to a rapid-response psychedelic for MDD and a new home-based approach for transcranial magnetic stimulation. These headlines illustrate both the challenges and progress in advancing mental healthcare.

A spouse’s unwavering refusal to admit any fault can cast a long shadow over a marriage. This piece highlights a partner’s struggle to feel heard and respected amid constant blame-shifting, illustrating how the absence of an apology can magnify resentment.

Every June, organizations like For All Seasons bring crucial attention to PTSD Awareness Month, highlighting the importance of understanding post-traumatic stress. This recognition supports broader efforts to ensure that individuals with PTSD know help is available.

Biogen will present new findings at the Alzheimer’s Association International Conference (AAIC) 2026, set for July 12–15 in London. This includes data from the Phase 2 CELIA study of diranersen, an investigational tau-targeting ASO, as well as additional analyses of LEQEMBI (lecanemab).

LEO Pharma A/S, a global medical dermatology leader, will present new data at the European Society of Contact Dermatitis (ESCD) Congress 2026 in Copenhagen. The findings will underscore the severity of chronic hand eczema (CHE) and call attention to ongoing gaps in patient care.

An 88-year-old who has lived with double vision for a decade found relief through prism lenses. After cataract surgery improved distance vision, the double vision continued, spotlighting the importance of addressing eye misalignment.

More Americans are surviving cancer, but for Morgan Newman, the diagnosis and its aftermath proved to be far more than just a physical challenge. Her story illustrates the persistent mental health obstacles survivors can face even after successful treatment.

A years-long struggle with thinning hair continues to weigh on a concerned patient who once believed the cause was a thyroid disorder. As her hair loss worsens without a clear explanation, the quest for answers becomes ever more pressing.

A new Phase 2 clinical trial is shining a spotlight on the potential benefits of Zabopegdutide for MASH patients. HistoIndex’s AI-powered analysis has revealed robust improvements in liver fibrosis, offering a promising glimpse of future treatment possibilities.

Syremis Therapeutics, a clinical-stage biopharmaceutical firm, has named Aaron Koenig, MD, as Chief Medical Officer. The appointment underscores the company’s mission to develop novel, impactful medicines for mental health disorders.

Feeling the midday slump? A quick puzzle might be just the boost you need as the inbox floods and your next meeting looms. Stepping away from your screen—even for a few minutes—could help you reset and regain focus.

Retirement can upend the comfortable rhythms of a household, especially when only one partner steps away from the workforce. Friends’ warnings and one spouse’s personal experience reveal how this domestic shift can cause both tension and humor in everyday life.

A preliminary study suggests that veterans with chronic musculoskeletal pain may benefit from accepting their pain rather than avoiding it. By embracing discomfort while maintaining meaningful activities, they could potentially reduce the link between pain intensity and alcohol use severity.

AstraZeneca has announced promising findings from a Phase III trial examining a novel liver cancer regimen. The combination of immunotherapies and targeted approaches, including IMFINZI, IMJUDO, lenvatinib, and transarterial chemoembolization (TACE), demonstrated a significant delay in disease progression.